APLS Dividend History & Analysis | N/A Yield
APLS has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Biotechnology
| Symbol | Market Cap USD | Dividend Yield TTM | Yield on Cost 5y |
|---|---|---|---|
| ABBV | 387,093 M | 3.34% | 7.54% |
| AMGN | 198,244 M | 3.21% | 5.93% |
| GILD | 176,133 M | 2.79% | 5.63% |
| HLN | 46,623 M | 1.76% | 2.46% |
| BIM | 13,627 M | 0.74% | 0.75% |
| Symbol | Market Cap USD | Growth Rate | Consistency |
|---|---|---|---|
| BTX | 1,425 M | 134% | 95.6% |
| HLN | 46,623 M | 30.1% | 100% |
| AMGN | 198,244 M | 7.84% | 100% |
| BIM | 13,627 M | 9.76% | 96.0% |
| ABBV | 387,093 M | 5.98% | 100% |
Quality Dividend Peers in Biotechnology
3.21% Yield
2.79% Yield
APLS Dividend History: as of February 2026
No dividends paid yet.APLS Dividend FAQ
Apellis Pharmaceuticals (NASDAQ:APLS) is a commercial-stage biotech that develops complement-inhibition therapies for high-unmet-need diseases. Its flagship product, EMPAVELI (pegcetacoplan), is approved for paroxysmal nocturnal hemoglobinuria (PNH) and is being pursued in several renal indications, while SYFOVRE targets geographic atrophy (GA) secondary to age-related macular degeneration. The firm also advances APL-3007, an siRNA candidate for GA, and leverages a partnership with Beam Therapeutics to explore base-editing approaches for complement-driven disorders.
What is the Dividend Yield of APLS?
As of February 2026, APLS`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 23.49.Does APLS pay a dividend?
As of February 2026 APLS does not pay a dividend.How often does APLS pay dividends?
Over the last 12 months, APLS has issued dividend payments.APLS dividend forecast
Based on historical data, the forecasted dividends per share for APLS for the next 4 payments are between 0 (+0.0%) and 0 (+0.0%).This suggests the dividend will remain relatively stable.
Will APLS pay dividends in 2026?
The next Ex-Dividend date for Apellis Pharmaceuticals (APLS) is currently unknown.What is the next Ex-Dividend Date for APLS?
The next Ex-Dividend date for Apellis Pharmaceuticals (APLS) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.What is the Dividend Growth of APLS?
APLS's average dividend growth rate over the past 5 years is -% per year.
What is the Yield on Cost of APLS?
APLS's 5-Year Yield on Cost is -%. If you bought APLS's shares at 49.12 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.What is the Payout Consistency of APLS?
APLS Payout Consistency is 0.0%.
The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Does APLS have a good Dividend Yield?
APLS`s % Dividend Yield is considered as unknown.What is the Dividend Payout Ratio of APLS?
The Dividend Payout Ratio of APLS is unknown.What is the Dividend Rating of APLS?
APLS`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.Key Metric Definitions
- Dividend Yield
- Annual dividend per share divided by current share price.
- Payout Ratio
- Percentage of earnings paid as dividends. Below 60% = safe, above 100% = unsustainable.
- Payout FCF
- Percentage of Free Cash Flow paid as dividends. More reliable than Payout Ratio since it measures actual cash.
- Growth Rate (CAGR)
- Compound annual growth rate of dividends over the last 5 years.
- Consistency
- Reliability of dividend payments over lifetime. Penalizes cuts and pauses.
- Yield on Cost
- Your effective yield if you bought 5 years ago. Shows dividend growth impact over time.
- Streak
- Consecutive years of dividend payments. 25+ years = Dividend Aristocrat.
- Dividend Rating
- Proprietary score (0-100) combining yield, growth, safety and consistency.
Last update: 2026-02-02 02:17